April 29, 2004

RTI International Forms New Organization to Provide Preclinical Support to Drug Companies

Media Contacts

  • News@rti.org
  • Lisa Bistreich-Wolfe
    919-316-3596
  • Kami Spangenberg
    919-485-5606

Group conducts chemical testing during drug development

RESEARCH TRIANGLE PARK, N.C. -- RTI International is forming a new preclinical support organization in analytical chemistry to perform drug analysis for commercial clients. Similar to the group that conducts government-focused drug testing at RTI, this new organization will develop methods to test the chemical composition of drugs, which is a crucial component of the drug development process.

The new group will be led by Jonathan Green, a pharmaceutical scientist with 17 years of experience. The commercial interests that Green's organization will serve include established as well as new biotechnology companies.

According to Green, the Food and Drug Administration mandates that every batch of a drug undergo a variety of tests to verify chemical makeup. "For example," he said, "on a bottle of Advil, you probably have seen that it has an expiration date. Someone developed the procedures to test and verify that date, such as performing a controlled study of the medication under different conditions. This is part of what my organization does -- all the chemical testing necessary to support registration of the drug."

Green has previously managed teams responsible for the development and validation of analytical and bioanalytical methods to support all aspects of drug development. Immediately before joining RTI, he was the principal of Analytical Consulting Services in Morrisville, N.C. He has also held leadership positions in analytical chemistry at Nobex Corporation, Magellan Laboratories Incorporated, Banner Pharmacaps, Inc., and DuPont Merck Pharmaceutical Company.

Green holds a doctorate in analytical chemistry from the University of North Carolina at Chapel Hill and a bachelor's degree in chemistry from Union College, Schenectady, N.Y. He serves on the advisory board for the newsmagazine of the American Association of Pharmaceutical Scientists, American Chemical Society.